Suo-Fu Qin

机构：Shenzhen Metro (China), Buchang Pharma (China)

发表论文 7 篇 · 总被引 99 次 · h-index 3

代表论文

• Tubular epithelial cells-derived small extracellular vesicle-VEGF-A promotes peritubular capillary repair in ischemic kidney injury (2022 · npj Regenerative Medicine · 被引 49)
• A comprehensive evaluation of stability and safety for HEK293F-derived extracellular vesicles as promising drug delivery vehicles (2025 · Journal of Controlled Release · 被引 30)
• Comprehensive Comparison of Extracellular Vesicles Derived from Mesenchymal Stem Cells Cultured with Fetal Bovine Serum and Human Platelet Lysate (2025 · ACS Nano · 被引 18)
• Targeting CH25H/25HC-ferroptosis axis: a novel mechanism of MSC-EVs mediated renoprotection in ischemic AKI (2026 · Journal of Nanobiotechnology · 被引 2)
• Safety evaluation of repeated administration of umbilical cord mesenchymal stem cell-derived exosomes (2026 · Stem Cell Research & Therapy)
• Mesenchymal stem cell-derived small extracellular vesicles suppress pyroptosis by delivering miR-125a-5p to improve acute kidney injury in sepsis (2026 · Cell Death Discovery)